ClinicalTrials.Veeva

Menu

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Enrolling

Conditions

Pancreatic Cancer

Treatments

Other: Observational study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.

Full description

Pancreatic cancer is a highly malignant gastrointestinal tumor with only a 10% overall 5-year survival rate. More than 80% of patients are already in the advanced stage when diagnosed, losing the chance of surgery. Advanced pancreatic cancer progresses rapidly and chemoradiotherapy has limited efficacy, so palliative care is thought to play an important role in the treatment process. However, due to the late development of palliative care, there is a lack of data on real-world clinical palliative care for pancreatic cancer patients in China.

This study investigates the real-world current status of palliative care for pancreatic cancer patients by sending a web questionnaire to the doctors from the Department of General Surgery in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland. The survey aims to obtain the real status of palliative care and achieve a comprehensive understanding of how to develop palliative care in hospitals.

The questionnaire includes both subjective standards like the surgeons' opinion on the development of palliative therapy and objective standards such as dedicated beds and teams for palliative care.

Enrollment

450 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Doctors from the General Surgery Department in Chinese public tertiary teaching hospitals and public primary care units
  • Approval to participate
  • Participants with a valid and complete questionnaire evaluated by 2 experienced surgeons

Exclusion criteria

  • Refusal to participate
  • Participants with an invalid or incomplete questionnaire

Trial design

450 participants in 1 patient group

Pancreatic cancer patients
Treatment:
Other: Observational study

Trial contacts and locations

1

Loading...

Central trial contact

Yuze Hua; Qiaofei Liu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems